3 news items
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AGIO
14 May 24
deep scientific expertise in classical hematology and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
AGIO
3 May 24
and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AGIO
2 May 24
, lifelong, debilitating hemolytic anemia. Building on the company's deep scientific expertise in classical hematology and leadership in the field
- Prev
- 1
- Next